Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNKS2 | Q9H2K2 | 15/20 | 1.00 |
| ▸ | TNKS | O95271 | 11/20 | 1.00 |
| ▸ | WNT3A | P56704 | 9/20 | 1.00 |
| ▸ | PARP1 | P09874 | 7/20 | 1.00 |
| ▸ | PARP2 | Q9UGN5 | 6/20 | 1.00 |
| ▸ | PARP3 | Q9Y6F1 | 2/20 | 1.00 |
| ▸ | PARP14 | Q460N5 | 1/20 | 1.00 |
| ▸ | PARP4 | Q9UKK3 | 1/20 | 1.00 |
| ▸ | AXIN2 | Q9Y2T1 | 1/20 | 1.00 |
| ▸ | BRD4 | O60885 | 1/20 | 0.51 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.50 |
| ▸ | COMT | P21964 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30870719 | 0.88 | TNKS2 (0.78) | TNKS2TNKSWNT3APARP1PARP2 | |
| SCHEMBL30870677 | 0.86 | TNKS2 (0.75) | TNKS2TNKSWNT3APARP1PARP2 | |
| SCHEMBL27438107 | 0.85 | TNKS2 (0.82) | TNKS2TNKSWNT3APARP1PARP2 | |
| SCHEMBL27438444 | 0.84 | TNKS2 (0.80) | TNKS2TNKSWNT3APARP1PARP2 | |
| SCHEMBL7776852 | 0.84 | TNKS2 (0.73) | TNKS2TNKSWNT3APARP1PARP2 | |
| SCHEMBL7783311 | 0.83 | TNKS2 (0.71) | TNKS2TNKSWNT3APARP1PARP2 | |
| SCHEMBL7782072 | 0.83 | TNKS2 (0.71) | TNKS2TNKSWNT3APARP1PARP2 | |
| SCHEMBL27436932 | 0.83 | TNKS2 (0.71) | TNKS2TNKSWNT3APARP1PARP2 | |
| SCHEMBL7783581 | 0.83 | TNKS2 (0.70) | TNKS2TNKSWNT3APARP1PARP2 | |
| SCHEMBL27436124 | 0.82 | TNKS2 (0.70) | TNKS2TNKSWNT3APARP1PARP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2082 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026106998-A1 | PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA)-TARGETED POLY(ADP-RIBOSE) POLYMERASE (PARP) INHIBITOR AND RELATED COMPOSITION AND METHOD OF USE | PURDUE RESEARCH FOUNDATION (US) | 2026-05-21 | — | — | WO | claimed |
| CN-122038285-A | Kit and method for constructing human bone organ by using pluripotent stem cells | 广东医科大学附属医院 | 2026-05-15 | — | — | CN | claimed |
| WO-2025251988-A9 | REAGENT COMBINATION OR KIT FOR CONSTRUCTING EMBRYOID AND USE THEREOF | 广州国家实验室 | 2026-05-15 | — | — | WO | claimed |
| EP-4739310-A1 | ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 (ENPP1) INHIBITOR COMBINATIONS AND USES THEREOF | Insilico Medicine IP Limited (HK) | 2026-05-13 | — | — | EP | claimed |
| US-12624339-B2 | Brain organoid containing optic vesicles generated based on H9 induction and eye-brain fusion culture method | TIANJIN UNIVERSITY (CN) | 2026-05-12 | — | — | US | claimed |
| US-20260124249-A1 | USE OF TNKS INHIBITORS FOR REGENERATION OF CARTILAGE | LIFLEX SCIENCE INC. (KR) | 2026-05-07 | — | — | US | claimed |
| US-20260125650-A1 | METHODS AND COMPOSITIONS FOR GENERATING HEPATOCYTES | TRAILHEAD BIOSYSTEMS INC (US) | 2026-05-07 | — | — | US | claimed |
| EP-4728051-A1 | STANDARDISING PLURIPOTENT STEM CELLS | United Kingdom Research and Innovation (GB) | 2026-04-22 | — | — | EP | claimed |
| EP-3964565-B1 | AN IN VITRO METHOD OF DIFFERENTIATING A HUMAN PLURIPOTENT STEM CELL POPULATION INTO A CARDIOMYOCYTE CELL POPULATION | NCARDIA B V (NL) | 2026-04-08 | — | — | EP | claimed |
| US-20260069600-A1 | COMBINATION DRUG | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2026-03-12 | — | — | US | claimed |
| US-10064862-B2 | Antiviral axin stabilizer | THE BOARD OF REGENTS FOR OKLAHOMA STATE UNIVERSITY (US) | 2018-09-04 | — | — | US | claimed |
| EP-3347456-A1 | METHOD FOR REPRODUCIBLE DIFFERENTIATION OF CLINICAL-GRADE RETINAL PIGMENT EPITHELIUM CELLS | The United States of America, as represented by The Secretary, Department of Health and Human Services (US) | 2018-07-18 | — | — | EP | claimed |
| US-20180195046-A1 | INDUCED EXTENDED PLURIPOTENT STEM CELLS, METHOD OF MAKING AND USING | PEKING UNIVERSITY (CN) | 2018-07-12 | — | — | US | claimed |
| EP-2951290-B1 | METHOD FOR GENERATING RETINAL PIGMENT EPITHELIUM (RPE) CELLS FROM INDUCED PLURIPOTENT STEM CELLS (IPSCS) | US HEALTH (US) | 2017-11-29 | — | — | EP | claimed |
| WO-2017044483-A1 | METHOD FOR REPRODUCIBLE DIFFERENTIATION OF CLINICAL-GRADE RETINAL PIGMENT EPITHELIUM CELLS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2017-03-16 | — | — | WO | claimed |
| US-20170065587-A1 | ANTIVIRAL AXIN STABLIZER | THE BOARD OF REGENTS FOR OKLAHOMA STATE UNIVERSITY | 2017-03-09 | — | — | US | claimed |
| EP-2951290-A2 | METHOD FOR GENERATING RETINAL PIGMENT EPITHELIUM (RPE) CELLS FROM INDUCED PLURIPOTENT STEM CELLS (IPSCs) | The United States of America, as represented by The Secretary, Department of Health and Human Services (US) | 2015-12-09 | — | — | EP | claimed |
| WO-2015134525-A1 | ANTIVIRAL AXIN STABILIZER | THE BOARD OF REGENTS FOR OKLAHOMA STATE UNIVERSITY (US) | 2015-09-11 | — | — | WO | claimed |
| WO-2014121077-A2 | METHOD FOR GENERATING RETINAL PIGMENT EPITHELIUM (RPE) CELLS FROM INDUCED PLURIPOTENT STEM CELLS (IPSCs) | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2014-08-07 | — | — | WO | claimed |
| US-20130273649-A1 | Culture medium for pluripotent stem cells | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2013-10-17 | — | — | US | claimed |